Yellow fever revaccination during infliximab therapy.

Arthritis care & research

Volumn 62, Issue 6, 2010, Pages 896-898

  Scheinberg, Morton ^a   Guedes Barbosa, Luis Sergio ^b   Mangueira, Cristovao ^b   Rosseto, Eliane Aparecida ^b   Mota, Licia ^b   Oliveira, Ana Cristina ^b   Lima, Rodrigo Aires ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY; YELLOW FEVER VACCINE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; YELLOW FEVER;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; YELLOW FEVER; YELLOW FEVER VACCINE;

MLCS; MLOWN;

EID: 77954506502     PISSN: None     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20045     Document Type: Article

References (0)